FDA.reportPublic FDA data

Dehydroepiandrosterone sulfate (DHEAS) IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of dehydroepiandrosterone sulfate (DHEAS) in a clinical specimen.
GUDID devices
7
Last updated
2025-03-28 11:03:01

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00630414632940Atellica IM DHEAS2 MCM SETSiemens Healthcare Diagnostics Inc.112091952025-03-20
00630414535340ADVIA Centaur® DHEA-S MCMSiemens Healthcare Diagnostics Inc.102822142020-09-24
00630414598802Atellica IM DHEAS MCMSiemens Healthcare Diagnostics Inc.109955562020-09-24
00630414979373IMMULITE® Systems DHS Calibration Verification Material DHEA-SO4SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD103879352020-09-24
00380740160739ARCHITECTAbbott GmbH08K27112020-03-03
00380740150631AlinityAbbott GmbH09P37102019-04-11
00380740017439ARCHITECTAbbott GmbH8K27-102016-06-06